GABAB receptor agonists and antagonists: pharmacological properties and therapeutic possibilities.
暂无分享,去创建一个
[1] B. Bettler,et al. Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors , 1997, Nature.
[2] N. Bowery,et al. GABA, glutamate and substance P‐like immunoreactivity release: effects of novel GABAB antagonists , 1996, British journal of pharmacology.
[3] R. Egan,et al. The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist. , 1995, The Journal of pharmacology and experimental therapeutics.
[4] O. Snead,et al. Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models. , 1995, The Journal of pharmacology and experimental therapeutics.
[5] J. Krause,et al. The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration , 1995, Neuroscience.
[6] N. Bowery,et al. Increased sensitivity to the antinociceptive activity of (±)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia , 1994, Neuropharmacology.
[7] M. Raiteri,et al. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes. , 1994, Molecular pharmacology.
[8] W. Froestl,et al. GABAB receptor antagonists: from synthesis to therapeutic applications. , 1993, Trends in pharmacological sciences.
[9] N. Bowery,et al. Gamma-aminobutyric acidB, but not gamma-aminobutyric acidA receptor activation, inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro. , 1993, The Journal of pharmacology and experimental therapeutics.
[10] M. Raiteri,et al. Multiple GABAB receptors. , 1993, Trends in pharmacological sciences.
[11] R. Egan,et al. Further evidence for prejunctional GABA-B inhibition of cholinergic and peptidergic bronchoconstriction in guinea pigs: studies with new agonists and antagonists. , 1993, Pharmacology.
[12] H. Bittiger,et al. Overview: Potent GABAB Agonists and Antagonists , 1993 .
[13] H. Nakayasu,et al. Immunoaffinity purification and characterization of gamma-aminobutyric acid (GABA)B receptor from bovine cerebral cortex. , 1993, The Journal of biological chemistry.
[14] D. Kerr,et al. Antagonism at GABAB receptors by saclofen and related sulphonic analogues of baclofen and GABA , 1989, Neuroscience Letters.
[15] D. Kerr,et al. 2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptors , 1988, Neuroscience Letters.
[16] D. R. Curtis,et al. Phaclofen: a peripheral and central baclofen antagonist , 1987, Brain Research.
[17] D. A. Brown,et al. GABAB-receptor-activated K+ current in voltage-clamped CA3 pyramidal cells in hippocampal cultures. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[18] L. Costa,et al. A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen , 1985, Neuropharmacology.
[19] R. Duman,et al. GABAB receptors and norepinephrine-stimulated cAMP production in rat brain cortex , 1984, Brain Research.
[20] N. Bowery,et al. Inhibition of GABAB Receptor Binding by Guanyl Nucleotides , 1984, Journal of neurochemistry.
[21] N. Bowery,et al. Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals. , 1981, European journal of pharmacology.
[22] J. Watkins,et al. The action of β-phenyl-GABA derivatives on neurones of the cat cerebral cortex , 1974 .
[23] D. R. Curtis,et al. Central effects of -(p-chlorophenyl)-?-aminobutyric acid , 1974 .
[24] S. Enna,et al. Characterization of the relationship between gamma-aminobutyric acid B agonists and transmitter-coupled cyclic nucleotide-generating systems in rat brain. , 1985, Molecular pharmacology.
[25] Hill Dr. GABAB receptor modulation of adenylate cyclase activity in rat brain slices. , 1985 .